In Vitro Activity of Novel Topoisomerase Inhibitors against Francisella tularensis and Burkholderia pseudomallei

Antimicrobial resistance is a global issue, and the investigation of alternative therapies that are not traditional antibiotics are warranted. Novel bacterial type II topoisomerase inhibitors (NBTIs) have recently emerged as a novel class of antibiotics with reduced potential for cross-resistance to...

Descripción completa

Detalles Bibliográficos
Autores principales: Whelan, Adam O., Cooper, Ian, Ooi, Nicola, Orr, David, Blades, Kevin, Kirkham, James, Lyons, Amanda, Barnes, Kay B., Richards, Mark I., Salisbury, Anne-Marie, Craighead, Mark, Harding, Sarah V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10326817/
https://www.ncbi.nlm.nih.gov/pubmed/37370302
http://dx.doi.org/10.3390/antibiotics12060983

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10326817/
https://www.ncbi.nlm.nih.gov/pubmed/37370302
http://dx.doi.org/10.3390/antibiotics12060983

Ejemplares similares